Correlation of Neurodegenerative Diseases with Oxidative Stress and Nutrition
Abstract
Technology or ease of doing work might be the greatest boon to this era, but it is still a bane for our health and life. Sitting in front of laptops or computers for several hours (sedentary lifestyle), using cell phones, watching television, skipping meals or eating junk/ fast food, lack of physical activities, stress, etc. increase the risk of many lifestyle diseases. All the above-mentioned habits increase the count of free radicals in our body and due to a lack of endogenous and exogenous antioxidants, the body cannot combat oxidative stress. Thus, the chances of occurrence of several chronic diseases like cancer, atherosclerosis, cardiovascular diseases, neurodegenerative diseases, rheumatoid arthritis, chronic inflammations, etc. increase. There are several factors contributing to neurodegeneration of the brain and neurons, in which oxidative stress plays an important role. This review article is the compilation of research done by several other researchers on Neurodegenerative Diseases (NDDs) and is primarily focused on better understanding a few basic questions like the correlation of oxidative stress and nutrition to neurodegeneration, NDDs, their different types, symptoms and causes followed by establishing a relation between oxidative stress and nutrition with the help of several studies carried out by researchers in this context.
How to cite this article:
Agarwal V, Singh S, Gupta R. Correlation of Neurodegenerative Diseases with Oxidative Stress and Nutrition. Chettinad Health City Med J. 2022;11(2):62-68.
DOI: https://doi.org/10.24321/2278.2044.202217
References
Tsagalioti E, Trifonos C, Morari A, Vadikolias K, Giaginis C. Clinical value of nutritional status in neurodegenerative diseases: what is its impact and how it affects disease progression and management? Nutr Neurosci. 2018;21(3):162-75. [PubMed] [Google Scholar]
Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD. The role of reactive oxygen species in the pathogenesis of Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease: a minireview. Oxid Med Cell Longev. 2016:1-15. [PubMed] [Google Scholar]
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev. 2017:1-11. [PubMed] [Google Scholar]
Sairazi NS, Sirajudeen KN. Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases. Evid Based Complement Alternat Med. 2020;1:1-30. [PubMed] [Google Scholar]
Healthline [Internet]. Brain disorders; 2018 [cited 2022 Apr 22]. Available from: https://www.healthline.com/health/brain-disorders
Mayo Clinic [Internet]. Alzheimer’s disease: symptoms and causes; 2022 [cited 2022 Apr 29]. Available from: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24(8):1583. [Google Scholar]
National Institute on Aging [Internet]. Parkinson’s disease: causes, symptoms, and treatments; 2017 [cited 2022 Mar 12]. Available from: https://www.nia.nih.gov/health/parkinsons-disease
Huntington’s Disease Society of America [Internet]. Overview of Huntington’s disease; 2020 [cited 2022 Feb 21]. Available from: https://hdsa.org/what-ishd/overview-of-huntingtons-disease/#:~:text=Is%20Huntington’s%20Disease%3F-,Huntington’s%20disease%20(HD)%20is%20a%20fatal%20genetic%20disorder%20that%20causes,years%20and%20has%20no%20cure
Mayo Clinic [Internet]. Multiple sclerosis; 2022 [cited 2022 Apr 29]. Available from: https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptomscauses/syc-20350269
Medical News Today [Internet]. Amyotrophic lateral sclerosis (ALS): symptoms, causes and diagnosis; 2022 [cited 2022 May 22]. Available from: https://www.medicalnewstoday.com/articles/281472
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017:1-13. [PubMed] [Google Scholar]
Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2016;53(6):4094-25. [PubMed] [Google Scholar]
Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65-74. [PubMed] [Google Scholar]
Joseph J, Cole G, Head E, Ingram D. Nutrition, brain aging and neurodegeneration. J Neurosci. 2009;29(41):12795-801. [PubMed] [Google Scholar]
Elufioye TO, Berida TI, Habtemariam S. Plants-derived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms. Evid Based Complement Alternat Med. 2017;2017:3574012. [PubMed] [Google Scholar]
Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30-43. [PubMed] [Google Scholar]
Chiu HF, Ventakatakrishnan K, Wang CK. The role of nutraceuticals as a complementary therapy against various neurodegenerative diseases: a mini-review. J Tradit Complement Med. 2020;10(5):434-9. [PubMed] [Google Scholar]
Emmerzaal TL, Kiliaan AJ, Gustafson DR. 2003-2013: a decade of body mass index, Alzheimer’s disease, and dementia. J Alzheimers Dis. 2015;43(3):739-55. [PubMed] [Google Scholar]
Wang J, Bi W, Cheng A, Freire D, Vempati P, Zhao W, Gong B, Janle EM, Chen TY, Ferruzzi MG, Schmeidler J, Ho L, Pasinetti GM. Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer’s disease-experimental approach and therapeutic implications. Front Aging Neurosci. 2014;6:42. [PubMed] [Google Scholar]
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012;72(4):578-86. [PubMed] [Google Scholar]
Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR, Okun E, Clarke K, Mattson MP, Veech RL. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer’s disease. Neurobiol Aging. 2013;34(6):1530-9. [PubMed] [Google Scholar]
Farah BA. Effects of caprylic triglyceride on cognitive performance and cerebral glucose metabolism in mild Alzheimer’s disease: a single-case observation. Front Aging Neurosci. 2014;6:133. [PubMed] [Google Scholar]
Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P. Vitamin D, cognition, and dementia: a systematic review and metaanalysis. Neurology. 2012;79(13):1397-405. [PubMed] [Google Scholar]
Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, Tschanz JT, Norton MC, Welsh-Bohmer KA. Prospective study of dietary approaches to stop hypertension- and mediterranean-style dietary patterns and age-related cognitive change: the cache county study on memory, health and aging. Am J Clin Nutr. 2013;98(5):1263-71. [PubMed] [Google Scholar]
Wirz KT, Keitel S, Swaab DF, Verhaagen J, Bossers K. Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase? J Alzheimers Dis. 2014;38(4):719-40. [PubMed] [Google Scholar]
Phan CW, David P, Sabaratanam V. Edible and medicinal mushrooms: emerging brain food for the mitigation of neurodegenerative diseases. J Med Food. 2017;20(1):1-6. [PubMed] [Google Scholar]
Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson’s disease. Front Aging Neurosci. 2014;6:1. [PubMed] [Google Scholar]
Kryozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopolous D, Trichopolous A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol. 2013;28(1):67-77. [PubMed] [Google Scholar]
Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson’s disease: results from a metaanalysis. Can J Neurol Sci. 2014;40(1):73-9. [PubMed] [Google Scholar]
Santos LF, Freitas RL, Xavier SM, Saldanha GB, Freitas RM. Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures. Pharmacol Biochem Behav. 2008;89(1):1-5. [PubMed] [Google Scholar]
Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472-7. [PubMed] [Google Scholar]
Morroni F, Tarozzi A, Sita G, Bolondi C, Moraga JM, Cantelli-Forti G, Hrelia P. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease. Neurotoxicology. 2013;36:63-71. [PubMed] [Google Scholar]
Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL. Neuroprotective properties of curcumin in toxinbase animal models of Parkinson’s disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017;17(1):412. [PubMed] [Google Scholar]
Nirankari S, Kamal R, Dhawan DK. Neuroprotective role of quercetin against arsenic induced oxidative stress in rat brain. J Environ Analyt Toxicol. 2016;6:359-64.
Trovato A, Siracusa R, Di Paola R, Scuto M, Ontario ML, Bua O, Di Mauro P, Toscano MA, Petralia CC, Maiolino L, Serra A, Cuzzocrea S, Calabrese V. Redox modulation of cellular stress response and lipoxin A4 expression by Hericium erinaceus in rat brain: relevance to Alzheimer’s disease pathogenesis. Immun Ageing. 2016;13:23. [PubMed] [Google Scholar]
Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer’s disease mouse model. Molecules. 2013;18(8):9949-65. [PubMed] [Google Scholar]
Okubo H, Miyake Y, Sasaki S, Murakami K, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group. Dietary patterns and risk of Parkinson’s disease: a case-control study in Japan. Eur J Neurol. 2012;19(5):681-8. [PubMed] [Google Scholar]
Sengupta T, Mohanakumar KP. 2-phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice. Neurochem Int. 2010;57(6):637-46. [PubMed] [Google Scholar]
